Jerry Lanchbury

Investor

Entrepreneur in Residence (EIR); former Chief Scientific Officer, Myriad Genetics at DigitalDx Ventures

About

Molecular diagnostics leader who directed teams at Myriad Genetics developing oncology, urology, rheumatology, and neuroscience diagnostics, including companion diagnostics for PARP inhibitors. Earlier roles included advisory and research leadership positions in immunogenetics; holds a BSc in Biology from Aston University and a PhD in Human Population Genetics from Newcastle University.

LinkedIn ↗